Company intelligence / Profile preview
EnGeneIC
Sydney, New South Wales, Australiaengeneic.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Currently in Phase 2a clinical trials for intractable cancers, including metastatic pancreatic cancer. Planning further clinical trials in Australia and USA.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Nanocell technology (EDV™ nanocell platform)Antibody-Nanocell Drug Conjugates (ANDCs)
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
03
Partnerships
BioCina (CDMO)St Vincent's Hospital (Melbourne, Australia)unnamed US-based hospital conglomerate
Beyond the preview
Go deeper on EnGeneIC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EnGeneIC.